{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:15:17Z","timestamp":1784243717338,"version":"3.55.0"},"reference-count":26,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Health IRCCS Foundation Policlinico San Matteo Grant","award":["948-rcr2019i2-46"],"award-info":[{"award-number":["948-rcr2019i2-46"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Antisynthetase syndrome (ASSD) is an autoimmune disease characterized by the positivity of autoantibodies against different aminoacyl transfer RNA (tRNA) synthetases. Morbidity and mortality of this disease are highly affected by interstitial lung disease (ILD) which is present in about 80% of patients. In this study, we investigated possible differences in 84 immune-related circulating miRNAs between ASSD patients with and without ILD; we enrolled 15 ASSD patients, 11 with ILD (ILD+) and 4 without ILD (ILD-), and 5 patients with idiopathic pulmonary fibrosis (IPF) as an additional control group. All patients were at disease onset and not on therapy at the time of inclusion. Differentially expressed miRNAs were identified in plasma-derived exosomes, using an miRNA PCR array (MIHS-111ZG, Qiagen, Hilden, Germany); miR-30a-5p and miR-29c-3p were upregulated in ASSD-ILD patients compared to patients without lung involvement (adjusted p-value &lt; 0.05). IPF patients showed higher miR-29c-3p expression levels with respect to both ASSD and ASSD-ILD (p = 0.0005), whereas levels of miR-30a-5p were not different. miR-29c-3p and miR-30a-5p are overexpressed in ASSD-ILD+ patients compared with ILD\u2212. These miRNAs are involved in the regulation of inflammation and fibrosis through their action on NF-\u03baB and TGF-\u03b21. Although the mechanistic role of these miRNAs in ASSD-ILD development has to be elucidated, we suggest that their exosome levels could be useful in identifying patients at risk of ILD.<\/jats:p>","DOI":"10.3390\/ijms232314579","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T03:15:24Z","timestamp":1669173324000},"page":"14579","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Proof-of-Concept Analysis of Plasma-Derived Exosomal microRNAs in Interstitial Pulmonary Fibrosis Secondary to Antisynthetase Syndrome"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2819-732X","authenticated-orcid":false,"given":"Sara","family":"Bozzini","sequence":"first","affiliation":[{"name":"Research Laboratory of Respiratory Disease, Section of Cell Biology, UOS Transplant Center, IRCCS Foundation Policlinico San Matteo, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5042-1282","authenticated-orcid":false,"given":"Giovanni","family":"Zanframundo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy"},{"name":"Division of Rheumatology, IRCCS Foundation Policlinico San Matteo, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Bagnera","sequence":"additional","affiliation":[{"name":"Research Laboratory of Respiratory Disease, Section of Cell Biology, UOS Transplant Center, IRCCS Foundation Policlinico San Matteo, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Bozza","sequence":"additional","affiliation":[{"name":"Research Laboratory of Respiratory Disease, Section of Cell Biology, UOS Transplant Center, IRCCS Foundation Policlinico San Matteo, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lettieri","sequence":"additional","affiliation":[{"name":"Pneumology Unit, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Vertui","sequence":"additional","affiliation":[{"name":"Pneumology Unit, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Codullo","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, IRCCS Foundation Policlinico San Matteo, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cuzzocrea","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, IRCCS Foundation Policlinico San Matteo, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7119-0786","authenticated-orcid":false,"given":"Bel\u00e9n","family":"Atienza-Mateo","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Epidemioogy, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Disease, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL, 39008 Santander, Spain"},{"name":"Department of Medicine and Psychiatry, Universidad de Cantabria, 39005 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4455-7241","authenticated-orcid":false,"given":"Sara","family":"Remuzgo Martinez","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Epidemioogy, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Disease, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL, 39008 Santander, Spain"},{"name":"Department of Medicine and Psychiatry, Universidad de Cantabria, 39005 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8263-3925","authenticated-orcid":false,"given":"Carlomaurizio","family":"Montecucco","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy"},{"name":"Division of Rheumatology, IRCCS Foundation Policlinico San Matteo, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7924-7406","authenticated-orcid":false,"given":"Miguel A.","family":"Gonz\u00e1lez-Gay","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Epidemioogy, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Disease, Hospital Universitario Marqu\u00e9s de Valdecilla, IDIVAL, 39008 Santander, Spain"},{"name":"Department of Medicine and Psychiatry, Universidad de Cantabria, 39005 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3292-1528","authenticated-orcid":false,"given":"Lorenzo","family":"Cavagna","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy"},{"name":"Division of Rheumatology, IRCCS Foundation Policlinico San Matteo, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Meloni","sequence":"additional","affiliation":[{"name":"Research Laboratory of Respiratory Disease, Section of Cell Biology, UOS Transplant Center, IRCCS Foundation Policlinico San Matteo, 27100 Pavia, Italy"},{"name":"Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1297-319X(03)00012-5","article-title":"Antisynthetase syndrome","volume":"70","author":"Hamidou","year":"2003","journal-title":"Jt. Bone Spine"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e1144","DOI":"10.1097\/MD.0000000000001144","article-title":"Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results from an International Retrospective Multicenter Study","volume":"94","author":"Cavagna","year":"2015","journal-title":"Medicine"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Cavagna, L., Trallero-Aragu\u00e1s, E., Meloni, F., Cavazzana, I., Rojas-Serrano, J., Feist, E., Zanframundo, G., Morandi, V., Meyer, A., and Pereira da Silva, J.A. (2019). Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. J. Clin. Med., 8.","DOI":"10.3390\/jcm8112013"},{"key":"ref_4","first-page":"e50","article-title":"Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria","volume":"77","author":"Cavagna","year":"2018","journal-title":"Ann. Rheum Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/BOR.0000000000000434","article-title":"Clinical spectrum of anti-Jo-1-associated disease","volume":"29","author":"Monti","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.autrev.2017.07.016","article-title":"How I treat idiopathic patients with inflammatory myopathies in the clinical practice","volume":"16","author":"Cavagna","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"W498","DOI":"10.1093\/nar\/gks494","article-title":"DIANA miRPath v.2.0: Investigating the combinatorial effect of microRNAs in pathways","volume":"40","author":"Vlachos","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/rheumatology\/keab753","article-title":"Plasma exosomal RNAs has potential as both clinical biomarkers and therapeutic targets of dermatomyositis","volume":"61","author":"Li","year":"2021","journal-title":"Rheumatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6676107","DOI":"10.1155\/2021\/6676107","article-title":"Plasma-Derived Exosomal hsa-miR-4488 and hsa-miR-1228-5p: Novel Biomarkers for Dermatomyositis-Associated Interstitial Lung Disease with Anti-Melanoma Differentiation-Associated Protein 5 Antibody-Positive Subset","volume":"2021","author":"Zhong","year":"2021","journal-title":"BioMed Res. Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"109390","DOI":"10.1016\/j.celrep.2021.109390","article-title":"MicroRNA miR-29c regulates RAG1 expression and modulates V(D)J recombination during B cell development","volume":"36","author":"Kumari","year":"2021","journal-title":"Cell Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/art.38292","article-title":"Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies","volume":"66","author":"Georgantas","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_12","first-page":"764","article-title":"hsa-miR-7 Is a Potential Biomarker for Idiopathic Inflammatory Myopathies with Interstitial Lung Disease in Humans","volume":"48","author":"Yu","year":"2018","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"119438","DOI":"10.1016\/j.lfs.2021.119438","article-title":"A regulatory loop among CD276; miR-29c-3p; and Myc exists in cancer cells against natural killer cell cytotoxicity","volume":"277","author":"Lee","year":"2021","journal-title":"Life Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bbrc.2011.06.191","article-title":"miR-29c targets TNFAIP3; inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma","volume":"411","author":"Wang","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40001-021-00566-y","article-title":"Clinical value and role of microRNA-29c-3p in sepsis-induced inflammation and cardiac dysfunction","volume":"26","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.2147\/JIR.S302832","article-title":"MiRNA-29c-3p Promotes Intestinal Inflammation via Targeting Leukemia Inhibitory Factor in Ulcerative Colitis","volume":"14","author":"Guo","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1139\/bcb-2014-0095","article-title":"The role of miR-29 in pulmonary fibrosis","volume":"93","author":"Cushing","year":"2015","journal-title":"Biochem. Cell Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1515\/med-2021-0319","article-title":"Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p","volume":"16","author":"Sun","year":"2021","journal-title":"Open Med. Wars. Pol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.bbadis.2019.06.004","article-title":"The Smad3-miR-29b\/miR-29c axis mediates the protective effect of macrophage migration inhibitory factor against cardiac fibrosis","volume":"1865","author":"Liang","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5167829","DOI":"10.1155\/2018\/5167829","article-title":"MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer","volume":"2018","author":"Jiang","year":"2018","journal-title":"J. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3389\/fimmu.2017.01977","article-title":"Severity of Systemic Inflammatory Response Syndrome Affects the Blood Levels of Circulating Inflammatory-Relevant MicroRNAs","volume":"8","author":"Caserta","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/1753425920971347","article-title":"MiR-30a-5p ameliorates LPS-induced inflammatory injury in human A549 cells and mice via targeting RUNX2","volume":"27","author":"Li","year":"2021","journal-title":"Innate Immun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1139\/cjpp-2021-0280","article-title":"miR-30a-5p inhibits the proliferation and collagen formation of cardiac fibroblasts in diabetic cardiomyopathy","volume":"100","author":"Yang","year":"2022","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"H1348","DOI":"10.1152\/ajpheart.00431.2020","article-title":"MicroRNA-30a-5p silencing polarizes macrophages toward M2 phenotype to alleviate cardiac injury following viral myocarditis by targeting SOCS1","volume":"320","author":"Zhang","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhang, S., Liu, H., Liu, Y., Zhang, J., Li, H., Liu, W., Cao, G., Xv, P., Zhang, J., and Lv, C. (2017). miR-30a as Potential Therapeutics by Targeting TET1 through Regulation of Drp-1 Promoter Hydroxymethylation in Idiopathic Pulmonary Fibrosis. IJMS, 18.","DOI":"10.20944\/preprints201701.0074.v1"},{"key":"ref_26","first-page":"5799","article-title":"Downregulation of microRNA-30a in bronchoalveolar lavage fluid from idiopathic pulmonary fibrosis patients","volume":"18","author":"Liu","year":"2018","journal-title":"Mol. Med. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/23\/14579\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:24:49Z","timestamp":1760145889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/23\/14579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":26,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["ijms232314579"],"URL":"https:\/\/doi.org\/10.3390\/ijms232314579","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,23]]}}}